There are several molecular/cellular pathways that potentially can explain this hypercoagulable state in COVID-19: it may involve ACE2, a carboxypeptidase responsible for the conversion of angiotensin II (Ang II) to angiotensin 1-7. Here, AGT is linked to thrombophilia.